Ad is loading...
CGEN
Price
$1.45
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
89 days until earnings call
CYTK
Price
$49.10
Change
+$1.43 (+3.00%)
Updated
Nov 22 closing price
89 days until earnings call
Ad is loading...

CGEN vs CYTK

Header iconCGEN vs CYTK Comparison
Open Charts CGEN vs CYTKBanner chart's image
Compugen
Price$1.45
Change-$0.00 (-0.00%)
Volume$145.84K
CapitalizationN/A
Cytokinetics
Price$49.10
Change+$1.43 (+3.00%)
Volume$1.64M
CapitalizationN/A
CGEN vs CYTK Comparison Chart
Loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CGEN vs. CYTK commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and CYTK is a StrongSell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (CGEN: $1.41 vs. CYTK: $49.10)
Brand notoriety: CGEN and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 117% vs. CYTK: 120%
Market capitalization -- CGEN: $127.76M vs. CYTK: $5.79B
CGEN [@Biotechnology] is valued at $127.76M. CYTK’s [@Biotechnology] market capitalization is $5.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • CGEN’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than CGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 4 TA indicator(s) are bullish while CYTK’s TA Score has 2 bullish TA indicator(s).

  • CGEN’s TA Score: 4 bullish, 5 bearish.
  • CYTK’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, CGEN is a better buy in the short-term than CYTK.

Price Growth

CGEN (@Biotechnology) experienced а 0.00% price change this week, while CYTK (@Biotechnology) price change was -2.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

CGEN is expected to report earnings on Feb 20, 2025.

CYTK is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.79B) has a higher market cap than CGEN($128M). CGEN YTD gains are higher at: -28.788 vs. CYTK (-41.191). CGEN has higher annual earnings (EBITDA): 10.6M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. CGEN (113M). CGEN has less debt than CYTK: CGEN (2.95M) vs CYTK (790M). CGEN has higher revenues than CYTK: CGEN (59.9M) vs CYTK (3.22M).
CGENCYTKCGEN / CYTK
Capitalization128M5.79B2%
EBITDA10.6M-481.94M-2%
Gain YTD-28.788-41.19170%
P/E Ratio47.00N/A-
Revenue59.9M3.22M1,861%
Total Cash113M1.01B11%
Total Debt2.95M790M0%
FUNDAMENTALS RATINGS
CGEN vs CYTK: Fundamental Ratings
CGEN
CYTK
OUTLOOK RATING
1..100
5274
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10050
SMR RATING
1..100
86100
PRICE GROWTH RATING
1..100
6059
P/E GROWTH RATING
1..100
721
SEASONALITY SCORE
1..100
2050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CGEN's Valuation (74) in the Biotechnology industry is in the same range as CYTK (100). This means that CGEN’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (50) in the Biotechnology industry is somewhat better than the same rating for CGEN (100). This means that CYTK’s stock grew somewhat faster than CGEN’s over the last 12 months.

CGEN's SMR Rating (86) in the Biotechnology industry is in the same range as CYTK (100). This means that CGEN’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Price Growth Rating (59) in the Biotechnology industry is in the same range as CGEN (60). This means that CYTK’s stock grew similarly to CGEN’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for CGEN (72). This means that CYTK’s stock grew significantly faster than CGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGENCYTK
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FJTSY17.880.15
+0.85%
Fujitsu Ltd.
BLGO0.18N/A
-0.28%
BioLargo, Inc.
LSRCY22.44-0.15
-0.66%
Lasertec Corp.
TCEHY51.20-1.00
-1.92%
Tencent Holding Ltd.
THNPY23.87-1.07
-4.27%
Technip Energies NV

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with NURPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then NURPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
-2.76%
NURPF - CGEN
46%
Loosely correlated
-9.14%
ASPHF - CGEN
41%
Loosely correlated
N/A
ORMP - CGEN
40%
Loosely correlated
+1.30%
CYTK - CGEN
38%
Loosely correlated
+3.00%
AXON - CGEN
36%
Loosely correlated
+0.90%
More